| Pharmaceutical active ingredients: |
| Fluticasone PropionateSalmeterol Xinafoate |
| Available forms, composition and doses of Advair Diskus: |
| Powder; Inhalation; Fluticasone Propionate 0.1 mg; Salmeterol Xinafoate 0.05 mg / dosePowder; Inhalation; Fluticasone Propionate 0.25 mg; Salmeterol Xinafoate 0.05 mg / dosePowder; Inhalation; Fluticasone Propionate 0.5 mg; Salmeterol Xinafoate 0.05 mg / dose |
| Advair Diskus medical category: |
| Human:Antiasthmatic and COPD preparationsOrally inhaled preparationsSelective beta-2-adrenergic agonists |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R01AD08 - FluticasoneR03AK06 - Salmeterol and other drugs for obstructive airway diseasesR03BA05 - Fluticasone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GlaxoSmithKline |
| Related documents and information about Advair Diskus: |
| Advair Diskus prescribing information (PDF)Advair Diskus medication guide (PDF)Advair HFA prescribing information (PDF)Advair HFA medication guide (PDF) |